Viral Oncology Therapies

This feed focuses on Viral Oncology Therapies, which exploits the ability of genetically engineered viruses to infect and kill cancer cells. Discover the latest research on Viral Oncology Therapies here.

June 17, 2020
Open Access

From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses

Cell Death Discovery
Julijan KabiljoMichael Bergmann
June 13, 2020
Open Access

Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies

Frontiers in Cell and Developmental Biology
Christos DogrammatzisMaria Kalamvoki
July 11, 2020

Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafish

Cancer Gene Therapy
David MealieaJ Andrea McCart
July 2, 2020

Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic

Cancer Gene Therapy
Joshua Del PapaRobin J Parks
June 26, 2020
Open Access

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication

Journal for Immunotherapy of Cancer
Erica B FloresEric Bartee
June 26, 2020
Open Access

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Nature Communications
Laura EvginRichard Vile
July 9, 2020
Case Report
Open Access

A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report

SAGE Open Medical Case Reports
Vladimirs SorokinsPēteris Alberts
June 18, 2020
Open Access

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib

Oncolytic Virotherapy
Laura V AshtonAmy L MacNeill
July 1, 2020
Open Access

The Double-Edged Sword Role of Viruses in Gastric Cancer

Paulina Niedźwiedzka-RystwejJacek Roliński
July 12, 2020

Targeted and immunotherapies in BRAF mutant melanoma - where we are standing and what to expect

The British Journal of Dermatology
X Bai, K T Flaherty
June 13, 2020

Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA

Molecular Therapy Oncolytics
Noura B ElsedawyAutumn J Schulze
July 1, 2020
Open Access

Oncolytic viruses for cancer immunotherapy

Journal of Hematology & Oncology
Otto HemminkiAkseli Hemminki
June 20, 2020

Chorioallantoic membrane (CAM) tumor model for evaluating oncolytic viruses

Human Gene Therapy
Lea KrutzkeStefan Kochanek
June 9, 2020

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Journal of Visualized Experiments : JoVE
Sameera VipatStefan Rothenburg

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

© 2020 Meta ULC. All rights reserved